Aktuelles | 24. 8月 2021

Discussion of compulsory licenses in the COVID-19 pandemic

With the Epidemic Protection Act of March 27, 2020, Germany declared an “emergency of national dimension” in view of the COVID-19 pandemic. At the same time, tensions and international pressure to “abrogate certain IP rights” increased. In addition to the Federal Republic of Germany, there are numerous other countries around the world that, in principle, can make use of emergency decrees to fundamentally restrict patent rights, such as in the United Kingdom, France, the United States, Canada, Israel, Australia, China, Japan and Korea. However, up to now, in the summer of 2021, neither an order for use (Section 13 PatG) nor – according to current knowledge – an action for a compulsory license (Section 24 PatG) has been brought before the courts responsible for this. The demand to be met is enormous, especially for vaccine developments that have been described as “game changers”.

The following download pdf summarize why this is so – despite numerous and strongly debated demands.

For more details follow the link

本网站使用的cookie是网站技术运行所必需的,并且总是被设置。其他cookies,用于个性化内容和广告,以及分析我们网站的流量,只有在您同意的情况下才会设置。我们还与我们的社交媒体、广告和分析合作伙伴分享有关您使用我们网站的信息。 更多信息